These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 26645875)

  • 1. Generalised cost-effectiveness analysis for breast cancer prevention and care in Hong Kong Chinese.
    Wong IO; Tsang JW; Cowling BJ; Leung GM
    Hong Kong Med J; 2015 Dec; 21 Suppl 6():9-12. PubMed ID: 26645875
    [No Abstract]   [Full Text] [Related]  

  • 2. Optimizing resource allocation for breast cancer prevention and care among Hong Kong Chinese women.
    Wong IO; Tsang JW; Cowling BJ; Leung GM
    Cancer; 2012 Sep; 118(18):4394-403. PubMed ID: 22359352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness analysis of mammography screening in Hong Kong Chinese using state-transition Markov modelling.
    Wong IO; Kuntz KM; Cowling BJ; Lam CL; Leung GM
    Hong Kong Med J; 2010 Jun; 16 Suppl 3():38-41. PubMed ID: 20601733
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cost-effectiveness of multiple screening modalities on breast cancer in Chinese women from Shanghai].
    Wu F; Mo M; Qin XX; Fang H; Zhao GM; Liu GY; Chen YY; Cao ZG; Yan YJ; Lyu LL; Xu WH; Shao ZM
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Dec; 38(12):1665-1671. PubMed ID: 29294584
    [No Abstract]   [Full Text] [Related]  

  • 5. Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness.
    Schousboe JT; Kerlikowske K; Loh A; Cummings SR
    Ann Intern Med; 2011 Jul; 155(1):10-20. PubMed ID: 21727289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost effectiveness of mammography screening for Chinese women.
    Wong IO; Kuntz KM; Cowling BJ; Lam CL; Leung GM
    Cancer; 2007 Aug; 110(4):885-95. PubMed ID: 17607668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A quest for quality and economic effectiveness throughout the continuum of breast care.
    La Fargue MM; Coleman C
    Breast; 2010 Aug; 19(4):251-2. PubMed ID: 20392641
    [No Abstract]   [Full Text] [Related]  

  • 8. What is the most cost-effective population-based cancer screening program for Chinese women?
    Woo PP; Kim JJ; Leung GM
    J Clin Oncol; 2007 Feb; 25(6):617-24. PubMed ID: 17308266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using the 21-gene assay to guide adjuvant chemotherapy decision-making in early-stage breast cancer: a cost-effectiveness evaluation in the German setting.
    Blohmer JU; Rezai M; Kümmel S; Kühn T; Warm M; Friedrichs K; Benkow A; Valentine WJ; Eiermann W
    J Med Econ; 2013; 16(1):30-40. PubMed ID: 22966753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost- Effectiveness of Mammography Screening Program in a Resource-Limited Post-Soviet Country of Kazakhstan.
    Salikhanov I; Crape B; Howie P
    Asian Pac J Cancer Prev; 2019 Oct; 20(10):3153-3160. PubMed ID: 31653167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluating the usefulness of a breast screening program in Bogotá, Colombia].
    González-Mariño MA
    Rev Salud Publica (Bogota); 2012; 14(1):41-52. PubMed ID: 23250314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Multigene Test Could Cost-Effectively Help Extend Life Expectancy for Women at Risk of Hereditary Breast Cancer.
    Li Y; Arellano AR; Bare LA; Bender RA; Strom CM; Devlin JJ
    Value Health; 2017 Apr; 20(4):547-555. PubMed ID: 28407996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health-related quality of life in patients with colorectal neoplasm and cost-effectiveness of colorectal cancer screening in Hong Kong.
    Lam CL; Law WL; Poon JT; Chan P; Wong CK; McGhee SM; Fong DY
    Hong Kong Med J; 2015 Dec; 21 Suppl 6():4-8. PubMed ID: 26645874
    [No Abstract]   [Full Text] [Related]  

  • 14. Cost-effectiveness of annual versus biennial screening mammography for women with high mammographic breast density.
    Pataky R; Ismail Z; Coldman AJ; Elwood M; Gelmon K; Hedden L; Hislop G; Kan L; McCoy B; Olivotto IA; Peacock S
    J Med Screen; 2014 Dec; 21(4):180-8. PubMed ID: 25186116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cost-effectiveness of prostate health index for prostate cancer detection in Chinese men.
    Teoh JY; Leung CH; Wang MH; Chiu PK; Yee CH; Ng CF; Wong MC
    Prostate Cancer Prostatic Dis; 2020 Dec; 23(4):615-621. PubMed ID: 32606435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of MRI for breast cancer screening in BRCA1/2 mutation carriers.
    Pataky R; Armstrong L; Chia S; Coldman AJ; Kim-Sing C; McGillivray B; Scott J; Wilson CM; Peacock S
    BMC Cancer; 2013 Jul; 13():339. PubMed ID: 23837641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the Cost-Effectiveness of Updated Breast Cancer Screening Guidelines for Average-Risk Women.
    Tina Shih YC; Dong W; Xu Y; Shen Y
    Value Health; 2019 Feb; 22(2):185-193. PubMed ID: 30711063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effective osteoporosis intervention thresholds for Hong Kong postmenopausal women.
    Kung AW; McGhee SM; Tsang SW; So J; Chau J
    Hong Kong Med J; 2015 Dec; 21 Suppl 6():13-6. PubMed ID: 26645876
    [No Abstract]   [Full Text] [Related]  

  • 19. The cost-effectiveness of digital breast tomosynthesis in a population breast cancer screening program.
    Wang J; Phi XA; Greuter MJW; Daszczuk AM; Feenstra TL; Pijnappel RM; Vermeulen KM; Buls N; Houssami N; Lu W; de Bock GH
    Eur Radiol; 2020 Oct; 30(10):5437-5445. PubMed ID: 32382844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of extended adjuvant letrozole therapy after 5 years of adjuvant tamoxifen therapy in postmenopausal women with early-stage breast cancer.
    Delea TE; Karnon J; Smith RE; Johnston SR; Brandman J; Sung JC; Gross PE
    Am J Manag Care; 2006 Jul; 12(7):374-86. PubMed ID: 16834524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.